Aerie Pharma (AERI) Misses Q4 EPS by 5c

Aerie Pharma (NASDAQ: AERI) reported Q4 EPS of ($0.92), $0.05 worse than the analyst estimate of ($0.87). Revenue for the quarter came in at $14.5 million versus the consensus estimate of $12.94 million.

For earnings history and earnings-related data on Aerie Pharma (AERI) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Star Equity Holdings (STRR) Misses Q2 EPS by 8c
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c